Bernhard Keppler

Bernhard K. Keppler is a German bioinorganic chemist and physician. He is chair of inorganic chemistry at the University of Vienna, head of the Institute of Inorganic Chemistry and dean of the Faculty of Chemistry.

Bernhard K. Keppler
Bernhard Keppler
NationalityGerman
Alma materUniversity of Heidelberg
DKFZ
AwardsHeinz Maier-Leibnitz-Preis (1991)
Scientific career
FieldsChemistry, Medicine
InstitutionsUniversity of Vienna
Notable studentsChristian Hartinger

Education and career

Keppler earned his diploma's degree in chemistry in 1979, Ph.D. in chemistry from the University of Heidelberg in 1981, licence to practice medicine (approbation) in 1984 and second Ph.D. in medicine from German Cancer Research Center in 1986. He was promoted to university lecturer in inorganic chemistry in 1990 at the University of Heidelberg and assigned a chair in inorganic chemistry at University of Vienna with tenure in 1995.[1] He is dean of the Faculty of chemistry since 2008, head of the inter-university research cluster Translational Cancer Therapy Research (in cooperation with the Medical University of Vienna and Prof. Walter Berger) and deputy head of the research network Chemistry, Microbiology and Environmental Systems Science (in cooperation with the Centre for Microbiology and Environmental Systems Science, University of Vienna, Prof. Michael Wagner).

Keppler is author and co-author of more than 550 papers in peer-reviewed journals, (~20.000 citations, H-index 74), 16 invited reviews, 50 book chapters, and numerous patents. He has edited several books (e.g. Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, 1993) and co-authored the textbook Principles of Bioinorganic Chemistry (University Science Books, 1994) with other scientists. He currently serves as an Associate Editor of the Anticancer Research. Keppler serves or has served on the editorial boards of numerous other journals.

Research interests

Keppler's research activities are at the interface of inorganic chemistry and biology. A major focus of his activities is to understand, improve and develop anticancer drugs. He is a pioneer in investigating metal-based anticancer drugs and developed the first-in-class compounds KP1339 (IT-139, Bold-100) and KP46 (IT-235 AP-002), which are currently under clinical studies. He also investigates environmental chemistry.

gollark: Deltashop *does* support no-name use, but only by routing krist income through Chervil's account via a proprietary and possibly unreliable server.
gollark: Oak has his own shop? I thought he used kMarx.
gollark: The parsing must involve a lot of regexomancy.
gollark: How could you be bothered to implement CSS in it anyway?
gollark: Plus everyone's custom solutions.

References
  1. Website Institute of Inorganic Chemistry
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.